Skip to main content
Medicine LibreTexts

5.7: Oestrogen

  • Page ID
    18553
  • While the use of oestrogen in the treatment of women with stress incontinence is controversial, its use in women with the irritative symptoms of OAB is more established. Postmenopausal women with genital atrophy or OAB symptoms may receive oral or topical therapy provided no contra – indications exist, but at present, oestrogen therapy for stress incontinence is unwise. As we wallow in post “Women’s Health Initiative” hype, we must remember the negative impact of withholding the beneficial effects of oestrogen on the pelvic floor, and not precipitate a host of symptoms caused by significant genital atrophy. Oestrogen is not useful for treating urinary incontinence, but may reduce the incidence of UTI’s.

    • Was this article helpful?